Monitor whether the sale proceeds as planned and watch for additional filings that may indicate larger-scale insider selling. Given the CEO's history of option exercises and the relatively small size of this proposed sale, it is not an immediate red flag, but continued insider outflows could signal reduced confidence.
Price Chart
Executive Summary
Bruce Cozadd, CEO of Jazz Pharmaceuticals, filed a Form 144 to propose the sale of 6,000 shares worth approximately $1.12 million. This is a routine, relatively small disposition that follows recent insider selling activity.
Key Facts
- Bruce C. Cozadd, CEO of Jazz Pharmaceuticals, is the reporting owner
- Proposed sale of 6,000 shares under Rule 144
- Approximate value of the proposed sale is $1,118,613.32
- Shares are from previously exercised stock options dated January 2022
- Filing date is April 1, 2026, with proposed sale date of March 3, 2026 (likely a typo or placeholder in filing)
- Recent insider activity includes two sells totaling $823K in the past 30 days
Financial Impact
Approximately $1.12 million in proposed sales, representing a small fraction of the company's $11.6B market cap and the CEO's overall holdings
Risk Factors
- Perception of insider selling ahead of potential company-specific or sector-wide catalysts
- Cumulative insider selling could erode investor confidence if trend continues
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-022784 |
| Document: 0001628280-26-022784-index.html | 0001628280-26-022784 |
| Document: 0001628280-26-022784.txt | 0001628280-26-022784 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Press Release | $213.76 $211.97 | ▼ −0.84% | ▼ −1.36% | $210.99 (−1.30%) |
Oct 9, 2026 17d ago | 8-K | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 8, 2026 17d ago | 144 | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 6, 2026 19d ago | 144 | $231.19 $222.45 | ▼ −3.78% | ▼ −3.36% | $210.99 (−8.74%) |
Oct 1, 2026 24d ago | 144 | $235.67 $236.04 | ▲ +0.16% | ▼ −0.52% | $210.99 (−10.47%) |
Sep 15, 2026 5w ago | 8-K | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 14, 2026 5w ago | Insider Cluster | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 10, 2026 6w ago | Insider Cluster | $245.80 $245.87 | ▲ +0.03% | ▲ +0.47% | $210.99 (−14.16%) |
Sep 2, 2026 7w ago | Insider Cluster | $247.57 $246.81 | ▲ +0.30% | ▼ −0.08% | $210.99 (+14.78%) |
Aug 31, 2026 7w ago | 144 | $243.71 $245.57 | ▲ +0.76% | ▲ +0.32% | $210.99 (−13.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers